Valentina Shakhnovich (V Shakhnovich)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Drug Administration

High Fat Diet Induced

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical and translational science

Expert opinion on drug metabolism & toxicology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Kathryn E Kyler, Andrea Gaedigk, Susan M Abdel-Rahman, Vincent S Staggs, Robin E Pearce, Paul Toren, James Steven Leeder, Valentina Shakhnovich
Influence of novel CYP2C-haplotype on proton pump inhibitor pharmacokinetics in children. Clinical and translational science 17 (4) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Kathryn E Kyler, Andrea Gaedigk, Susan M Abdel-Rahman, Vincent S Staggs, Robin E Pearce, Paul Toren, James Steven Leeder, Valentina Shakhnovich
Influence of novel CYP2C-haplotype on proton pump inhibitor pharmacokinetics in children. Clinical and translational science 17 (4) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Elizabeth J Thompson, Angela Jeong, Victória Etges Helfer, Valentina Shakhnovich, Andrea N Edginton, Stephen J Balevic, Laura P James, David N Collier, Ravinder Anand, Daniel Gonzalez, null null
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT: pharmacometrics & systems pharmacology (2024)
Kathryn E Kyler, Andrea Gaedigk, Susan M Abdel-Rahman, Vincent S Staggs, Robin E Pearce, Paul Toren, James Steven Leeder, Valentina Shakhnovich
Influence of novel CYP2C-haplotype on proton pump inhibitor pharmacokinetics in children. Clinical and translational science 17 (4) (2024)
Kathryn E Kyler, Andrea Gaedigk, Susan M Abdel-Rahman, Vincent S Staggs, Robin E Pearce, Paul Toren, James Steven Leeder, Valentina Shakhnovich
Influence of novel CYP2C-haplotype on proton pump inhibitor pharmacokinetics in children. Clinical and translational science 17 (4) (2024)
Rachel Chevalier, Thomas Mario Attard, Sara L Van Driest, Valentina Shakhnovich
A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens. Expert opinion on drug metabolism & toxicology (2023)
Farwa Jafri, Zachary L Taylor, Daniel Gonzalez, Valentina Shakhnovich
Effects of obesity on the pharmacology of proton pump inhibitors: current understanding and future implications for patient care and research. Expert opinion on drug metabolism & toxicology (2023)
Tracy Sandritter, Rachel Chevalier, Rebecca Abt, Valentina Shakhnovich
Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Tracy Sandritter, Rachel Chevalier, Rebecca Abt, Valentina Shakhnovich
Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Rachel Chevalier, Thomas Mario Attard, Sara L Van Driest, Valentina Shakhnovich
A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens. Expert opinion on drug metabolism & toxicology (2023)
Abbey Elsbernd, Boutaina Boulouadnine, Atif A Ahmed, Midhat S Farooqi, Tracy Sandritter, Valentina Shakhnovich, Darius Blanding, Jean-Baptiste Demoulin, Joel Thompson
Novel Oncogenic <i>PDGFRB</i> Variant in Severe Infantile Myofibromatosis With Response to Imatinib Using Therapeutic Drug Monitoring. JCO precision oncology 6 (2022)
Kenneth Schmidt, Janelle Noel-MacDonnell, Carrie Vyhlidal, Daniel P Heruth, Vivekanand Singh, Atif A Ahmed, Taina Hudson, Veronica Williams, Valentina Shakhnovich
Characterization of the Mucosally-Adherent Duodenal Microbiome in Children with and without Crohn's Disease. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Kathryn E Kyler, Jonathan Wagner, Chelsea Hosey-Cojocari, Kevin Watt, Valentina Shakhnovich
Drug Dose Selection in Pediatric Obesity: Available Information for the Most Commonly Prescribed Drugs to Children. Paediatric drugs 21 (5) (2019)
Valentina Shakhnovich, S Abdel-Rahman, C A Friesen, J Weigel, R E Pearce, A Gaedigk, J S Leeder, G L Kearns
Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity. Pediatric obesity 14 (1) (2018)